Fialuridine

Fialuridine
Clinical data
Other names	2′-Fluoro-5-iodouracil
ATC code	none;
Identifiers
	IUPAC name 1-[(2R,3S,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)- 2-tetrahydrofuranyl]-5-iodopyrimidine-2,4-dione;
CAS Number	69123-98-4 ;
PubChem CID	50313;
ChemSpider	45627 ;
UNII	53T7IN77LC;
KEGG	D04181 ;
ChEMBL	ChEMBL271475 ;
NIAID ChemDB	070971;
Chemical and physical data
Formula	C9H10FIN2O5
Molar mass	372.091 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c1c(c(=O)[nH]c(=O)n1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)F)I;
	InChI InChI=1S/C9H10FIN2O5/c10-5-6(15)4(2-14)18-8(5)13-1-3(11)7(16)12-9(13)17/h1,4-6,8,14-15H,2H2,(H,12,16,17)/t4-,5+,6-,8-/m1/s1 ; Key:IPVFGAYTKQKGBM-BYPJNBLXSA-N ;
	(what is this?) (verify)

Fialuridine, or 1-(2-deoxy-2-fluoro-1-D-arabinofuranosyl)-5-iodouracil (FIAU), is a nucleoside analogue that was investigated as a potential therapy for hepatitis B virus infection. In a 1993 clinical study at the NIH, unexpected toxicity led to the death of 5 out of 15 patients from liver failure alongside lactic acidosis; two further participants required liver transplantation. It is suspected that the toxicity of fialuridine was a result of mitochondrial damage caused by the incorporation of fialuridine into mitochondrial DNA via its 3'-hydroxyl moiety, leading to impaired DNA synthesis. This toxicity was unusual in that it was not predicted by animal studies.^[1]^[2]^[3]

References

^ Tujios S, Fontana RJ (April 2011). "Mechanisms of drug-induced liver injury: from bedside to bench". Nature Reviews. Gastroenterology & Hepatology. 8 (4): 202–11. doi:10.1038/nrgastro.2011.22. PMID 21386809. S2CID 1329655.
^ McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, et al. (October 1995). "Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B". The New England Journal of Medicine. 333 (17): 1099–105. doi:10.1056/NEJM199510263331702. PMID 7565947.
^ Thomson L (1 March 1994). "The Cure that Killed". Discover Magazine. Retrieved 2 November 2013.

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

[1] Tujios S, Fontana RJ (April 2011). "Mechanisms of drug-induced liver injury: from bedside to bench". Nature Reviews. Gastroenterology & Hepatology. 8 (4): 202–11. doi:10.1038/nrgastro.2011.22. PMID 21386809. S2CID 1329655.

[2] McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, et al. (October 1995). "Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B". The New England Journal of Medicine. 333 (17): 1099–105. doi:10.1056/NEJM199510263331702. PMID 7565947.

[3] Thomson L (1 March 1994). "The Cure that Killed". Discover Magazine. Retrieved 2 November 2013.

[1]

[2]

[3]